Academia’s role in drug repositioning: an interview with Dr. S Joshua Swamidass
Dr. S Joshua Swamidass, Assistant Professor, Washington University School of Medicine, took the time to speak with us on the role of academia in the multi-stakeholder collaboration initiatives towards drug repositioning.
We asked Joshua several questions about academia’s role in drug repositioning including:
- What is the key difference in the way academia and industry approach repositioning?
- What is a good model for collaborations between academia and industry?
- Have there been any surprises for you in your collaborations with pharmaceutical company researchers?
- How does academia and collaborations worked to overcome the issue of MTA’s getting stuck between legal offices at either academia or industry?
Dr. S Joshua Swamidass will be speaking at World Drug Repositioning Congress USA, taking place in Washington, DC this December. He will be presenting on the topic, ‘Phenotypic screening data to suggest repurposing opportunities at an early stage’.
To hear him share his insights, make sure you attend World Drug Repositioning Congress USA!